pargyline has been researched along with Sleep Initiation and Maintenance Disorders in 2 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Sleep Initiation and Maintenance Disorders: Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MOSER, M | 1 |
| BRODOFF, B | 1 |
| MILLER, A | 1 |
| GOLDMAN, AG | 1 |
| KOHN, RM | 1 |
2 other studies available for pargyline and Sleep Initiation and Maintenance Disorders
| Article | Year |
|---|---|
PARGYLINE TREATMENT OF HYPERTENSION. EXPERIENCE WITH A NONHYDRAZINE AMINE OXIDASE INHIBITOR.
Topics: Antihypertensive Agents; Diuretics; Erectile Dysfunction; Geriatrics; Humans; Hypertension; Hypotens | 1964 |
NOCTURNAL ORTHOSTATIC SYNCOPE IN PARGYLINE THERAPY.
Topics: Antihypertensive Agents; Erectile Dysfunction; Humans; Hypotension; Hypotension, Orthostatic; Male; | 1964 |